<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157900">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01682993</url>
  </required_header>
  <id_info>
    <org_study_id>367/2009</org_study_id>
    <nct_id>NCT01682993</nct_id>
  </id_info>
  <brief_title>Corneal Cross Linking and Topography Guided Excimer Laser Treatment</brief_title>
  <official_title>Topography Guided Excimer Laser Surface Ablation in Combination With Corneal Cross-linking (CCL) in Patients With Progressive Ectatic Corneal Disorders.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Topography guided laser treatment enables the surgeon to correct higher order aberrations in
      corneas with irregular astigmatism. Several case reports and small uncontrolled trials have
      been published on the combination of this treatment with corneal cross linking (CCL) in
      patients with ectatic corneal diseases.

      This randomized study will evaluate the safety and efficacy of a combined treatment of
      corneal cross linking with a partial topography guided excimer laser treatment in eyes with
      progressive ectatic corneal diseases.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2010</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety (Pachymetry, K-readings)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>uncorrected visual acuity (UVCA)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>best corrected visual acuity (BCVA)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression of ectatic disease (by use of maximum keratometry readings = Kmax)</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Keratoconus</condition>
  <condition>Pellucid Marginal Degeneration</condition>
  <arm_group>
    <arm_group_label>Corneal Cross Linking</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a standard corneal cross linking treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corneal Cross Linking and Topo Laser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive a topography guided laser treatment in combination with a standard corneal cross linking treatment in the same session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Topography guided Excimer Laser treatment and Corneal Cross Linking</intervention_name>
    <description>A topography guided excimer laser treatment will be performed prior to CCL in one session.</description>
    <arm_group_label>Corneal Cross Linking and Topo Laser</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Corneal Cross Linking</intervention_name>
    <description>A standard corneal cross linking procedure will be performed in this arm.</description>
    <arm_group_label>Corneal Cross Linking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent

          -  Patient age 18 - 40 years

          -  Documented progressive corneal ectatic disease except post LASIK/LASEK ectasia

        Exclusion Criteria:

          -  Allergy to one of the used substances

          -  Tendency towards excessive scar formation

          -  Pregnancy

          -  Rheumatic diseases

          -  Central corneal thickness below 450 Âµm

          -  Active infection of the study eye

          -  Previous corneal surgery of the study eye
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of Ophthalmology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 4, 2013</lastchanged_date>
  <firstreceived_date>November 5, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerald Schmidinger</investigator_full_name>
    <investigator_title>MD, Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>corneal cross linking</keyword>
  <keyword>topography guided excimer laser</keyword>
  <keyword>Keratoconus</keyword>
  <keyword>Pellucid marginal degeneration</keyword>
  <keyword>Post Excimer ectasia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Keratoconus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
